Hyundai Pharmaceutical Co., Ltd. Stock: price and insider trades · South Korea
현대약품
No insider purchase over the last 90 days. The latest, by 신풍제약, was filed 04 Mar 2026.
Hyundai Pharmaceutical Co., Ltd.: what insiders have been doing
We have very little insider data for Hyundai Pharmaceutical Co., Ltd. so far: the most recent filing dates from 4 March 2026. With so few records, no pattern can be drawn yet. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -35.0%Entry ₩10,270 · Close 29 Oct 2026 ₩6,680
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended November 2025 · cache
- 2,307,929 sharesKRXDART:20260304001381Canonical exit: 28 May 2026 (T+90)
1 of 1 declaration
About Hyundai Pharmaceutical Co., Ltd.
Hyundai Pharmaceutical is a South Korean company specializing in the healthcare and pharmaceutical sector. It is listed on the XKRX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
